circNEIL3 inhibits tumor metastasis through recruiting the E3 ubiquitin ligase Nedd4L to degrade YBX1

Shuang Chen(Sichuan University), Ke Li(Sichuan University), Jiawei Guo(Sichuan University), Hai‐Ning Chen(Sichuan University), Yue Ming(Sichuan University), Jin Yang(Sichuan University), Fuyan Xu(Sichuan University), Tingting Zhang(Sichuan University), Yang Yang(Sichuan University), Zixia Ye(Sichuan University), Wenrong Liu(Sichuan University), Hulin Ma(Sichuan University), Jian Cheng(Sichuan University), Jiankang Zhou(Sichuan University), Zhang Li(Sichuan University), Shu Yi Shen(Sichuan University), Lunzhi Dai(Sichuan University), Zong‐Guang Zhou(Sichuan University), Heng Xu(Sichuan University), Yong Peng(Sichuan University)
Proceedings of the National Academy of Sciences
March 24, 2023
Cited by 91Open Access
Full Text

Abstract

Distant metastasis is a major contributor to cancer-related mortality. However, the role of circRNAs in this process remains unclear. Herein, we profiled the circRNA expression in a cohort of 68 colorectal carcinoma (CRC) primary tumors and their paired liver metastatic lesions. By overlapping with the TGFβ-responsive circRNAs, circNEIL3 (hsa_circ_0001460) was identified as a TGFβ-repressive and metastasis-related circRNA. Functionally, circNEIL3 effectively inhibited tumor metastasis in both and in vivo and in vivo models of various cancer types. Mechanistically, circNEIL3 exerts its metastasis-repressive function through its direct interaction with oncogenic protein, Y-box-binding protein 1 (YBX1), which consequently promotes the Nedd4L-mediated proteasomal degradation of YBX1. Importantly, circNEIL3 expression was negatively correlated to YBX1 protein level and metastatic tendency in CRC patient samples. Collectively, our findings indicate the YBX1-dependent antimetastatic function of circNEIL3 and highlight the potential of circNEIL3 as a biomarker and therapeutic option in cancer treatment.


Related Papers

No related papers found

Powered by citation graph analysis